DOCETAXEL ACTAVIS 20mg / ml perfusive solution concentrate medication leaflet

L01CD02 docetaxel • Antineoplastic and immunomodulating agents | Plant alkaloids and other natural products | Taxanes

Docetaxelum is a chemotherapy drug used for the treatment of various types of cancer, including breast cancer, lung cancer, and prostate cancer. It belongs to the taxane class and works by inhibiting cell division, preventing the growth and spread of cancer cells.

The medication is administered intravenously, usually as part of a specific regimen, under the supervision of an oncologist. It is effective in reducing tumor size and prolonging patient survival.

Side effects may include nausea, vomiting, hair loss, neutropenia, and, in rare cases, severe allergic reactions. Close monitoring is essential during treatment.

Consult your doctor to discuss the benefits and risks of treatment with Docetaxelum. This medication must be administered exclusively in controlled environments, such as hospitals.

General data about DOCETAXEL ACTAVIS 20mg / ml

Substance: docetaxel

Date of last drug list: 01-06-2025

Commercial code: W55902001

Concentration: 20mg / ml

Pharmaceutical form: perfusive solution concentrate

Quantity: 1

Product type: generic

Price: 101.53 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: SINDAN - PHARMA S.R.L. - ROMANIA

Holder: TEVA PHARMACEUTICAL S.R.L. - ROMANIA

Number: 11654/2019/01

Shelf life: 2 years-after packing for marketing;after the first opening of the bottle-it is used immediately

Pharmaceutical forms available for docetaxel

Concentrations available for docetaxel

10mg/ml, 120mg/6ml, 160mg/8ml, 20mg, 20mg/0.5ml, 20mg/1ml, 20mg/ml, 40mg/ml, 80mg, 80mg/2ml, 80mg/4ml

Other substances similar to docetaxel

Compensation lists for DOCETAXEL ACTAVIS 20mg / ml ACTAVIS

NHP 3 (C2) - NHP oncology

Price

Copayment

Patient

101.53 RON

87.49 RON

14.04 RON